Open AccessOutcomes After Transcervical Thymectomy for Ocular Myasthenia Gravis: A Retrospective Cohort Study With Inverse Probability Weighting
Author(s) -
Ali G. Hamedani,
Maxwell Pistilli,
Sunil Singhal,
Kenneth S. Shindler,
Robert A. Avery,
Madhura A. Tamhankar,
Grant T. Liu
Publication year - 2020
Publication title -
journal of neuro-ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.586
H-Index - 55
eISSN - 1536-5166
pISSN - 1070-8022
DOI - 10.1097/wno.0000000000000814
Subject(s) - thymectomy , medicine , prednisone , myasthenia gravis , ocular myasthenia , edrophonium , retrospective cohort study , plasmapheresis , repetitive nerve stimulation , cohort , surgery , pediatrics , antibody , immunology
The benefit of thymectomy in reducing requirement for corticosteroids, symptom severity, need for immunosuppression, and hospitalization rates in patients with seropositive generalized myasthenia has recently been established. It is unclear whether this benefit applies to patients with myasthenia and purely ocular manifestations (ocular myasthenia gravis [OMG]).